SNWV Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 -0.25%, SMA50 -9.51%, SMA200 -22.46%). The stock’s 14-day RSI is 44.92 (neutral), while the ATR of 1.27 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -46.16% below its high and over 7.64% above its low. Average 10-day trading volume of 356.77 thousand shares is significantly above the 3-month average of 142.56 thousand, indicating heightened recent market interest.

SANUWAVE Health Inc. has 8.57 million shares outstanding. The public float is 4.93 million shares, elevated short interest at 8.22% of float. This equals 442.33 thousand shares. The short ratio is 9.22 days. Institutional investors hold 47.86% of the float. Insiders own 1.31%. Stolarski Anthony Michael holds 17.01 million shares, Richardson Kevin A II has 7.15 million shares and Parikh Shri P. has 1.00 million shares. Over the past six months, insider transactions show net selling. They sold 10.20 thousand shares across 6 transactions.

SANUWAVE Health Inc. generated EPS of -$1.69 over the past year. Five-year average earnings growth is 18.26%. Analyst sentiment is bullish. Analyst rating data shows there are 1 Strong Buy ratings, 3 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $55.00 to $47.00. The high target offers 538.79% upside. The low target suggests 445.88% downside. The mean target is $51.50. This offers 498.14% upside. SANUWAVE Health Inc. earnings surprise history is a mixed track record. The quarter that ended May 12, 2026, missed forecasts by 21.43%. The prior quarter beat by -82.35%. Over the last six quarters, Apple has recorded several small beats. These include -187.2% in August 15, 2022.

SANUWAVE Health Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$7.72. This means the shares are trading below this model’s fair value.

SANUWAVE Health Inc. trades at a P/E ratio of 4.9, slightly below the S&P 500 average, with a price-to-sales ratio of 1.67 and a price-to-book ratio of 40.24 reflecting a rich premium to book value. The P/FCF stands at 12.63, also above market averages. Compared to sector medians, SANUWAVE Health Inc. P/S is trading at a discount to the sector, and the P/B is far higher than peers, underscoring the brand and earnings power premium investors assign to the stock.

SANUWAVE Health Inc. (NASDAQ:SNWV) closed at $8.61 USD, gaining $0.98 (12.84%) from the previous close of $7.63. The stock is currently mid-range between its 52-week high and low $7.53 and $46.59. With a market capitalization of about $74.04 million, SANUWAVE Health Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.34). Key stats such as the average daily volume over the past year has been around 136.82 thousand shares, trading with heavier-than-usual volume. Headquartered in Eden Prairie, MN, SANUWAVE Health Inc. operates in the Healthcare sector and the Medical - Equipment & Services industry. Led by CEO Morgan C. Frank, the company employs approximately 55 people and listed since October 18, 2024. SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices.

Our AI price prediction model suggests that SANUWAVE Health Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -29.85%, with price expected at $6.04 by July 10, 2026, within a range of $3.87 to $8.29 3-Month Outlook: Projected fall of -1.51%, reaching $8.48 by September 24, 2026, with a range of $7.73 to $9.47. 1-Year Outlook: Projected loss of -67.02%, with price at $2.84 by June 25, 2027, within a range of $1.64 to $4.32.

SANUWAVE Health Inc. (NASDAQ:SNWV) shares are flat -7.47% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows SANUWAVE Health Inc. trading at a premium to the broader market with a P/E of 4.9. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $51.50, suggesting 498.14% upside. Our AI forecast model points to short-term weakness (-29.85% over two weeks), a medium-term fall (-1.51% over three months), and a longer-term loss (-67.02% over one year), with expected trading ranges indicating moderate volatility.